James Weisberger
Chief Tech/Sci/R&D Officer at BIO-REFERENCE LABORATORIES INC
Profile
James Weisberger is currently the Chief Medical Officer & EVP-Laboratory Director at Bio-Reference Laboratories, Inc. He previously worked as the Hematopathology Director at IMPATH, Inc. from 1999 to 2003 and as an Assistant Professor at New York Medical College from 1995 to 1999.
He completed his undergraduate and graduate degrees at Stanford University in 1977 and 1978 respectively, and obtained his doctorate degree from the University of Pennsylvania in 1983.
James Weisberger active positions
| Companies | Position | Start |
|---|---|---|
| BIO-REFERENCE LABORATORIES INC | Chief Tech/Sci/R&D Officer | 2003-08-31 |
Former positions of James Weisberger
| Companies | Position | End |
|---|---|---|
| IMPATH, Inc. | Corporate Officer/Principal | 2002-12-31 |
| New York Medical College | Corporate Officer/Principal | 1998-12-31 |
Training of James Weisberger
| Stanford University | Graduate Degree |
| University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Bio-Reference Laboratories, Inc.
 Bio-Reference Laboratories, Inc. Medical/Nursing ServicesHealth Services Bio-Reference Laboratories, Inc. engages in the provision testing and related services to physicians, clinics, hospitals, long-term care facilities, employers, government units, and correctional institutions. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology, services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology and other tissue analysis. The firm focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional health care. The company was founded by Marc D. Grodman in 1981 and is headquartered in Elmwood Park, NJ. | Health Services |
| IMPATH, Inc. | Health Services |
- Stock Market
- Insiders
- James Weisberger
